Consultation responses on the Reimbursement Committee’s recommendation concerning the reimbursement status of medicines for treatment of depression and anxiety (ACT group N06A, etc.)
The Reimbursement Committee’s recommendation on the future reimbursement status of medicines in ATC group N06A, antidepressants, as well as certain medicines in ATC groups N03A, N05A and N05B was open for consultation until 15 August 2011.
The Danish Medicines Agency received 9 consultation responses. The box to the right contains links to the consultation responses (in Danish only) and the Danish Medicines Agency’s announcement of 6 May 2011, where you can also find the Reimbursement Committee’s recommendation.
The Reimbursement Committee discussed the consultation responses at its meeting on 23 August 2011 and found no basis to change its recommendation.
The Danish Medicines Agency now deliberates to reach a decision.